XML 49 R29.htm IDEA: XBRL DOCUMENT
v3.25.1

Net Loss per Share (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Earnings Per Share [Abstract] |
Schedule of computation of basic and diluted net loss per share | The following table sets forth the computation of basic and diluted net loss per share for the years ended December 31, 2024 and 2023 and the period from July 11, 2022 through December 31, 2022 (in thousands, except share and per share amounts):
| For the Years Ended December 31, |  |  | Period from July 11, 2022 through December 31, |
| 2024 |  |  | 2023 |  |  | 2022 |
Numerator |  |  |  |  |  |  |  |
Net loss | $ | (163,335 | ) |  | $ | (135,447 | ) |  | $ | (54,503 | )
Less: Net loss attributable to noncontrolling interests |  | (102,149 | ) |  |  | (99,979 | ) |  |  | (40,103 | )
Net loss available to Class A ordinary shareholders of ProKidney Corp., basic and diluted | $ | (61,186 | ) |  | $ | (35,468 | ) |  | $ | (14,400 | )
Denominator |  |  |  |  |  |  |  |
Weighted average Class A ordinary shares or ProKidney Corp. outstanding, basic and diluted |  | 97,916,193 |  |  |  | 61,714,225 |  |  |  | 61,540,231 |
Net loss per Class A ordinary share |  |  |  |  |  |  |  |
Net loss per Class A ordinary share of ProKidney Corp., basic and diluted | $ | (0.62 | ) |  | $ | (0.57 | ) |  | $ | (0.23 | )
Outstanding anti-dilutive securities not included in the diluted net loss per share calculation include the following:
| As of December 31, |
| 2024 |  |  | 2023 |  |  | 2022 |
Antidilutive securities |  |  |  |  |  |  |  |
ProKidney Corp. Class B ordinary shares |  | 163,693,707 |  |  |  | 168,297,916 |  |  |  | 171,578,320 |
Unvested Restricted Stock Rights |  | 1,755,686 |  |  |  | 3,565,753 |  |  |  | 8,369,796 |
Earnout Rights |  | 17,500,000 |  |  |  | 17,500,000 |  |  |  | 17,500,000 |
Legacy SCS Restricted Share Units |  | – |  |  |  | – |  |  |  | 50,000 |
Stock options granted under the 2022 Equity Incentive Plan |  | 21,449,920 |  |  |  | 14,680,109 |  |  |  | 9,504,715 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration